Markets:

Overview

News

Currencies

International

Treasuries

Sanofi - American Depositary Shares (NQ:SNY)

49.25 +0.62 (+1.27%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 11, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Sanofi - American Depositary Shares

< Previous 1 2

...

28 29 30 31 32 33 34 35 36

...

40 41 Next >

Clovis Oncology (CLVS) Stock Rallies on Buyout Rumors ↗

June 14, 2022

Pharmaceutical startup CLVS stock is climbing 25% higher today on rumors that the cancer drug maker has become a takeover target.

Via InvestorPlace

Morning Brief: Top Financial Stories Dominating on Monday, June 13 ↗

June 13, 2022

CNBC JPMorgan Remains Bullish On Alibaba And Other Chinese Stocks - Here’s Why

Via Benzinga

Sanofi-GSK's Next-Gen COVID-19 Booster Shows Potential Against Variants Of Concern ↗

June 13, 2022

Via Benzinga

We're Looking At Obesity In A New Way — And 4 Pharmaceutical Stocks Could Benefit ↗

June 10, 2022

The conversation around obesity is changing. Two diabetes drug makers are at the forefront.

Via Investor's Business Daily

Pfizer’s CDI Trial Miss Puts Acurx Pharmaceuticals Ibezapolstat In Front-Line Position, Here’s Why Big Pharma May Come Calling ($ACXP)

June 09, 2022

Via AB Newswire

FDA Accepts Regeneron, Sanofi's Filing For Review In Skin Disease ↗

May 31, 2022

The U.S.

Via Benzinga

Why Kymera Therapeutics Shares Are Falling Today ↗

May 03, 2022

Via Benzinga

The Daily Biotech Pulse: FDA Adcomm Backing For Novavax's COVID-19 Shot, New Data On Moderna's Omicron Vaccine, DBV Tech's Encouraging Peanut Allergy Trial Data ↗

June 08, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

U.S. FDA Approves Regeneron And Sanofi's Lead Drug For Skin Inflammation In Children ↗

June 07, 2022

The U.S.

Via Benzinga

CStone Pharma Replaces Chairman Amid Huge Losses, Irregular Investment ↗

June 07, 2022

Key Takeaways: CStone brought four products to market last year, and its losses have surged due to growing R&D and sales spending Appointment of chairman with close ties...

Via Benzinga

Acurx Pharmaceuticals Is Under The Radar, That’s Excellent News For Investors Wanting Exposure To Billion Dollar CDI Treatment Market ($ACXP)

June 06, 2022

Via AB Newswire

The Week Ahead In Biotech (June 5-11): Adcom Test For Novavax, ASCO Presentations, Enzo Biochem Earnings And More ↗

June 05, 2022

Biotech stocks reversed course along with the broader market and closed the week ending June 3 lower. The sector's lean run thus got extended.

Via Benzinga

Regeneron Pharmaceuticals Dives On $1.1 Billion Deal To Rival Merck In Cancer ↗

June 02, 2022

Regeneron secured the global rights to Sanofi-partnered Libtayo.

Via Investor's Business Daily

3 Biotech Stocks to Buy Before They Boom ↗

June 01, 2022

It could be a “never-before, never-after opportunity” to buy into these biotech stocks that trade at very attractive valuations.

Via InvestorPlace

Attention Biotech Investors: Mark Your Calendar For These June PDUFA Dates ↗

May 31, 2022

May turned out to be a month of mixed fortunes as far as regulatory reviews are concerned. New molecular entity approvals, an indicator of innovation in drug research, totaled three during the month,...

Via Benzinga

Revolutionary Heart Therapy Offers Hope to Patients and Investors Alike

May 31, 2022

Palm Beach, FL – May 31, 2022 – FinancialNewsMedia.com News Commentary – Diabetes is a chronic health condition that occurs when your body’s blood glucose, also called blood sugar, is too high. Blood...

Via FinancialNewsMedia

The Week Ahead In Biotech (May 22-28): Verrica, Bristol-Myers Squibb FDA Decisions, Medtronic Earnings, Conference Presentations & More ↗

May 22, 2022

Biotech stocks advanced in the week ending May 22, defying the broader market retreat. The defensive nature of the industry and stock-specific moves lent support.

Via Benzinga

FDA Approves Regeneron and Sanofi's Dupixent (dupilumab) For Eosinophilic Esophagitis (EoE) Ahead of Schedule ↗

May 20, 2022

The U.S. Food and Drug Administration (FDA) has approved Regeneron Pharmaceuticals, Inc.

Via Benzinga

The Daily Biotech Pulse: CDC Recommends COVID-19 Boosters For Kids 5-11, Foghorn's Blood Cancer Trial On Clinical Hold, Bayer Intends To Bow Out From CAR-T Therapy Pact With Atara ↗

May 20, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

7 Penny Stocks With 10x Potential This Year ↗

May 17, 2022

These penny stocks all have 10x potential or greater during the remainder of 2022. They are risky but relatively straightforward.

Via InvestorPlace

Sanofi To Pay €400K As Compensation For Epilepsy Drug-Related Side Effects ↗

May 16, 2022

A French court has ordered Sanofi SA (NASDAQ: SNY) to pay more than €400,000 in damages to a French family whose child had autism caused by its epilepsy drug Valproate.

Via Benzinga

Sanofi Says Sarclisa Shows 'Unprecedented Median Progression-Free Survival' In Multiple Myeloma Patients ↗

May 16, 2022

Via Benzinga

Eli Lilly, Novo Nordisk, Sanofi Accused Of Artificially Raising Insulin Prices ↗

May 13, 2022

Arkansas has accused Eli Lilly And Co (NYSE: LLY), Novo Nordisk A/S (NYSE: NVO), Sanofi SA (NASDAQ: SNY), and three of the largest pharmacy benefit...

Via Benzinga

Why Tech Leader Regeneron Shouldn't Sweat Its AbbVie Rival — For Now ↗

May 13, 2022

The race is on in eczema treatment as the biggest name faces new rivals.

Via Investor's Business Daily

Psychedelic Medicine: The New Frontier In Healthcare, The Big Opportunity In Biopharma ↗

May 13, 2022

The story around psychedelic medicine continues to get bigger.

Via Talk Markets

Is Dario (DRIO) Health Eating Teladoc's (TDOC) Lunch? Q1 Earnings on Tap Thursday After Meeting with Sanofi (SNY) ↗

May 11, 2022

Teladoc (NYSE: TDOC) stock recently cratered to a new 52 week low following it’s Q1 report. Some of it’s shortfall was attributed by management to longer sales cycles in the insurer and employer space...

Via Benzinga

The Daily Biotech Pulse: Veru Shares Up On COVID Candidate Update, FDA Approves Lilly's COVID Treatment, Latest On Sanofi-AstraZeneca RSV Vaccine ↗

May 11, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Sanofi-AstraZeneca Say New Nirsevimab Data Reinforce Efficacy Against RSV ↗

May 11, 2022

Sanofi SA (NASDAQ: SNY) and AstraZeneca plc (NASDAQ: AZN) have announced results from a prespecified pooled analysis of nirsevimab in respiratory syncytial virus (RSV).

Via Benzinga

Heart Failure Treatment Offers Hope to Diabetics

May 11, 2022

Palm Beach, FL – May 11, 2022 – FinancialNewsMedia.com News Commentary – Diabetes and heart failure are closely linked. People with type 2 diabetes are two to four times more likely to develop heart...

Via FinancialNewsMedia

7 Biotech Stocks With Key Catalysts for May ↗

May 11, 2022

The beaten-down state of biotech stocks is a major pulling point for investors who are aiming for market-leading returns.

Via InvestorPlace

< Previous 1 2

...

28 29 30 31 32 33 34 35 36

...

40 41 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sanofi - American Depositary Shares (NQ:SNY)

All News about Sanofi - American Depositary Shares

Starting at $3.75/week.

Subscribe Today